▸A. Elkamhawy, U.M. Ammar, S. Paik, M.H. Abdellattif, M.H. Elsherbeny, K. Lee, E.J. Roh*, Molecules, Scaffold Repurposing of In-House Small Molecule Candidates Leads to Discovery of First-in-Class CDK-1/HER-2 Dual Inhibitors: In Vitro and In Silico Screening, 2021, 26 (17), 5324.
▸A. Elkamhawy, S. Paik, J-H. Park, H.J. Kim, A.H.E. Hassan, K. Lee, K.D. Park, E.J. Roh*, Bioorganic chemistry, Discovery of novel and potent safinamide-based derivatives as highly selective hMAO-B inhibitors for treatment of Parkinson's disease (PD): Design, synthesis, in vitro, in vivo and in silico biological studies, 2021 (115), 105233.
▸A. Elkamhawy, E.M.H. Ali, K. Lee, Journal of Enzyme Inhibition and Medicinal Chemistry, New horizons in drug discovery of lymphocyte-specific protein tyrosine kinase (Lck) inhibitors: a decade review (2011–2021) focussing on structure–activity relationship (SAR) and docking insights, 2021, 36, 1574-1602.
▸A. Elkamhawy, Q. Lu, H. Nada, J. Woo, G. Quan, K. Lee, International Journal of Molecular Sciences, The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer, 2021, 22 (12), 6535.
▸H. Nada, A. Elkamhawy, K. Lee, Molecules, Structure Activity Relationship of Key Heterocyclic Anti-Angiogenic Leads of Promising Potential in the Fight against Cancer, 2021, 26 (3), 553.
▸A. Elkamhawy, S. Paik, H. J. Kim, J-H. Park, A. M. Londhe, K. Lee, A. N. Pae, K. D. Park, E. J. Roh, Journal of Enzyme Inhibition and Medicinal Chemistry, Discovery of N-(1-(3-fluorobenzoyl)-1H-indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B, 35 (2020) 1568-1580.
▸A. Elkamhawy, N.Y. Kim, A.H.E. Hassan, J.E. Park, S. Paik, J.E. Yang, K.S. Oh, B.H. Lee, M.Y. Lee, K.J. Shin, A.N. Pae, K.T. Lee, E.J. Roh, European journal of Medicinal Chemistry, Thiazolidine-2,4-dione-based irreversible allosteric IKK- β inhibitors: Optimization into in vivo anti-inflammatory agents, 188 (2020), 111955.
▸A. Elkamhawy, N.Y. Kim, A.H.E. Hassan, J.E. Park, J.E. Yang, M.H. Elsherbeny, S. Paik, K.S. Oh, B.H. Lee, M.Y. Lee, K.J. Shin, A.N. Pae, K.T. Lee, E.J. Roh*, Bioorganic chemistry, Optimization study towards more potent thiazolidine-2,4-dione IKK-β modulator: Synthesis, biological evaluation and in silico docking simulation, 92 (2019), 103261.
▸A. Elkamhawy, J.E. Park, A.H.E. Hassan, A.N. Pae, J. Lee, S. Paik, B. G. Park, E.J. Roh*, European Journal of Medicinal Chemistry, Pyrazinyl ureas revisited: 1-(3-(Benzyloxy)pyrazin-2-yl)-3-(3,4-dichlorophenyl)urea, a new blocker of Aβ-induced mPTP opening for Alzheimer’s disease, 157 (2018), 268-278.